Sen. James M. Inhofe bought Editas Medicine (EDIT)
Sen. James M. Inhofe (R-OK) · $15K–$50K · traded Oct 19, 2017
- Transaction
- Bought
- Amount
- $15K–$50K
- Owner
- The member
- Traded
- Oct 19, 2017
- Disclosed
- Nov 8, 2017
- Days to disclose
- 20
- Asset type
- Stock
- As filed
- Editas Medicine, Inc.
- Industry
- Biotechnology · Healthcare
Other trades in this filing
- Nov 8, 2017$100K–$250K
$100K–$250K · Traded Oct 23, 2017 · disclosed Nov 8, 2017
- Nov 8, 2017$15K–$50K
$15K–$50K · Traded Oct 23, 2017 · disclosed Nov 8, 2017
- Nov 8, 2017$50K–$100K
$50K–$100K · Traded Oct 23, 2017 · disclosed Nov 8, 2017
- Nov 8, 2017$15K–$50K
Bought Alibaba Group Holding Limited BABA
$15K–$50K · Traded Oct 23, 2017 · disclosed Nov 8, 2017
- Nov 8, 2017$15K–$50K
Bought CRISPR Therapeutics AG CRSP
$15K–$50K · Traded Oct 19, 2017 · disclosed Nov 8, 2017
- Nov 8, 2017$15K–$50K
Bought Intellia Therapeutics NTLA
$15K–$50K · Traded Oct 19, 2017 · disclosed Nov 8, 2017
- Nov 8, 2017$15K–$50K
$15K–$50K · Traded Oct 17, 2017 · disclosed Nov 8, 2017
- Nov 8, 2017$50K–$100K
Sold (full) The Walt Disney Company DIS
$50K–$100K · Traded Oct 13, 2017 · disclosed Nov 8, 2017
- Nov 8, 2017$1K–$15K
$1K–$15K · Traded Oct 12, 2017 · disclosed Nov 8, 2017
- Nov 8, 2017$50K–$100K
$50K–$100K · Traded Oct 11, 2017 · disclosed Nov 8, 2017
Recent Congress trades in EDIT
- May 19, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
$1K–$15K · Traded Apr 10, 2023 · disclosed May 19, 2023
- Dec 20, 2019$15K–$50K
Sen. James M. Inhofe (R-OK)
Sold (full) Editas Medicine EDIT
$15K–$50K · Traded Feb 4, 2019 · disclosed Dec 20, 2019 · filed 319 days later
- Feb 25, 2019$15K–$50K
Sen. James M. Inhofe (R-OK)
Sold (full) Editas Medicine EDIT
$15K–$50K · Traded Feb 4, 2019 · disclosed Feb 25, 2019
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.